InVision-Plus® CS (Chlorhexidine Silver)

About RyMed Technologies

RyMed Technologies, founded in 2003 and headquartered in Franklin, Tennessee, is a private medical device company commercializing its proprietary InVision-Plus® needle-free IV connectors. Its core technology, Neutral Advantage Technology, is built around a '10-Point Standard' that addresses key failure points in IV therapy, such as infection and occlusion, through a fail-safe engineering design. The company is revenue-generating with a commercial-stage product line, recently expanding into pediatric and NICU populations. RyMed operates in the competitive vascular access segment, positioning its products as a premium standard for safety and clinical efficacy.

Therapeutic Areas